Cargando…

Reply to: Correspondence relating to “SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19”

Detalles Bibliográficos
Autores principales:	Wang, Yijin, Lu, Fengmin, Zhao, Jingmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Association for the Study of the Liver. Published by Elsevier B.V. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309894/ https://www.ncbi.nlm.nih.gov/pubmed/32589896 http://dx.doi.org/10.1016/j.jhep.2020.06.028

Ejemplares similares

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
por: Wang, Yijin, et al.
Publicado: (2020)

Drug induced hepatitis and SARS-CoV-2 vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Reply to: ‘No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease’
por: Ji, Dong, et al.
Publicado: (2020)

Reply to: “Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!”
por: Rabinowich, Liane, et al.
Publicado: (2022)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

Reply to “Intensification of an Essential Tremor by SARS-CoV-2”
por: Passaretti, Massimiliano, et al.
Publicado: (2022)

Correspondence on “Lack of vaccination in ventilated patients for SARS-CoV-2 in France”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Seroconversion after Inactive SARS-CoV-2 Vaccination and Obesity: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Central diabetes insipidus, hypophysitis and SARS-CoV-2 vaccine: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post-SARS-CoV-2 vaccination COVID toes and fingers correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 related liver impairment – perception may not be the reality
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

SARS-CoV-2 mRNA vaccination, prostate cancer and steroids: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Reply to: Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)
por: López-Mendez, Ivan, et al.
Publicado: (2021)

Reply to “Ample evidence suggests SARS-CoV-2 triggers polyradiculitis”
por: Esteban Molina, A., et al.
Publicado: (2022)

Reply to “Ample evidence suggests SARS-CoV-2 triggers polyradiculitis”
por: Esteban Molina, A., et al.
Publicado: (2022)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Delayed skin reactions and mRNA vaccines against SARS-CoV-2: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Reply to the letter to the editor: “impact of SARS-CoV-2 vaccines on the nervous system”
por: Corrêa, Diogo Goulart, et al.
Publicado: (2022)

Reply to Letter to Editor: Is SARS-CoV-2 responsible for relapses of Parkinson’s disease?
por: Kamel, Walaa A., et al.
Publicado: (2021)

Response to R. Mungmumpuntipanip and V. Wiwantikit: Correspondence to “Post-SARS-CoV-2 vaccination COVID toes and fingers”
por: Wollina, Uwe
Publicado: (2022)

Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: correspondence
por: Mungmunpuntipanjtip, Rujittika, et al.
Publicado: (2022)

Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply
por: Franchini, Massimo, et al.
Publicado: (2023)

In Reply — Neutralization of Fecal Aerosol-Laden SARS CoV-2: Public Health Implications
por: McDermott, Carmen V., et al.
Publicado: (2021)

Author’s reply to the Letter to the Editor “The study of olfactory dysfunction in SARS-CoV-2 variants”
por: Hintschich, Constantin A., et al.
Publicado: (2022)

Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine()
por: Flores-Rebollar, Armando
Publicado: (2022)

Reply to “Indications and timing for tracheostomy in patients with SARS CoV2‐related” by Ferri et al.
por: Mattioli, Francesco, et al.
Publicado: (2020)

Reply to “Does hand hygiene reduce SARS-CoV-2 transmission?”
por: Lai, Tracy H. T., et al.
Publicado: (2020)

Impaired lung regeneration after SARS‐CoV‐2 infection
por: Shao, Hongxia, et al.
Publicado: (2020)

Parenteral nutrition in SARS-CoV-2 patients on non-invasive ventilation: A reply - Letter to the editor
por: Subramanian, Kritika, et al.
Publicado: (2022)

Reply to Letter to the Editor: “How Does SARS-CoV-2 Fragment the QRS?”
por: Halil Özdemir, İbrahim, et al.
Publicado: (2022)

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Iavarone, Massimo, et al.
Publicado: (2020)

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
por: Heida, Judith E., et al.
Publicado: (2021)

In reply to: IL-6 serum level and olfactory dysfunction severity in COVID-19: correspondence
por: Vaira, Luigi Angelo, et al.
Publicado: (2022)

Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
por: Kamura, Yuya, et al.
Publicado: (2022)

Reply to Radermacher et al. on “Serum Hydrogen Sulfide and Outcome Association in Pneumonia by the SARS-CoV-2 Coronavirus”
por: Renieris, Georgios, et al.
Publicado: (2021)

In Reply: SARS-CoV-2 Vaccination Related, Pediatric Guillain-Barre Syndrome Requires the Same Management as in Adults
por: Gunawan, Pricilla Yani
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2p5l58edg7scl1um0nmlqngt9